Collegium Pharmaceutical Inc (COLL)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 228,842 | 195,431 | 194,842 | 202,928 | 186,031 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $228,842K
= 0.00
The debt-to-equity ratio for Collegium Pharmaceutical Inc has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not utilized any debt to finance its operations during this period, relying solely on equity to fund its activities. A debt-to-equity ratio of 0.00 suggests that the company is not taking on any financial leverage and is operating with a conservative capital structure. While a low debt-to-equity ratio can be seen as a positive indicator of financial stability and risk management, it may also imply limited flexibility in capital utilization or growth opportunities that could be achieved through debt financing.
Peer comparison
Dec 31, 2024